Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Clinical Hypertension
|
September 1, 1986
Evaluation of verapamil in the treatment of hypertension
S N Anavekar, A E Doyle
Diabetes & Metabolism
|
July 23, 2013
The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes
P Iyngkaran, N Anavekar, W Majoni, et al.
Clinical Science and Molecular Medicine. Supplement
|
June 1, 1975
Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression
W J Louis, A E Doyle, S N Anavekar
European Journal of Clinical Pharmacology
|
January 1, 1982
Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects
S N Anavekar, B Jarrott, M Toscano, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1978
The rate of development of new drugs in the United States, 1963 through 1975
W M Wardell, M Hassar, S N Anavekar, et al.
Journal of Cardiovascular Pharmacology
|
July 1, 1979
Evaluation of indapamide in the treatment of hypertension
S N Anavekar, A Ludbrooke, W J Louis, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1981
Verapamil in the treatment of hypertension
S N Anavekar, N Christophidis, W J Louis, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1982
A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease
S N Anavekar, C Barter, W R Adam, et al.
Journal of Clinical Pharmacology
|
May 1, 1992
Pharmacokinetic comparison of a slow-release clonidine with a conventional formulation after acute and chronic administration in hypertensives
E L Conway, S N Anavekar, L G Howes, et al.
Seminars in Nephrology
|
February 28, 2012
Cardio-renal syndrome: new perspective in diagnostics
P Iyngkaran, H Schneider, P Devarajan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Clinical Hypertension
|
September 1, 1986
Evaluation of verapamil in the treatment of hypertension
S N Anavekar, A E Doyle
Diabetes & Metabolism
|
July 23, 2013
The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes
P Iyngkaran, N Anavekar, W Majoni, et al.
Clinical Science and Molecular Medicine. Supplement
|
June 1, 1975
Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression
W J Louis, A E Doyle, S N Anavekar
European Journal of Clinical Pharmacology
|
January 1, 1982
Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects
S N Anavekar, B Jarrott, M Toscano, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1978
The rate of development of new drugs in the United States, 1963 through 1975
W M Wardell, M Hassar, S N Anavekar, et al.
Journal of Cardiovascular Pharmacology
|
July 1, 1979
Evaluation of indapamide in the treatment of hypertension
S N Anavekar, A Ludbrooke, W J Louis, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1981
Verapamil in the treatment of hypertension
S N Anavekar, N Christophidis, W J Louis, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1982
A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease
S N Anavekar, C Barter, W R Adam, et al.
Journal of Clinical Pharmacology
|
May 1, 1992
Pharmacokinetic comparison of a slow-release clonidine with a conventional formulation after acute and chronic administration in hypertensives
E L Conway, S N Anavekar, L G Howes, et al.
Seminars in Nephrology
|
February 28, 2012
Cardio-renal syndrome: new perspective in diagnostics
P Iyngkaran, H Schneider, P Devarajan, et al.
Page
of 2